What question did this study set out to answer?

To evaluate the effectiveness of ECMO in managing severe RSV-induced ARDS in an infant post-HSCT.

April 16, 2026Open Access

Navigating Challenges: Extracorporeal Membrane Oxygenation for Respiratory Syncytial Virus Acute Respiratory Distress Syndrome in a Post-hematopoietic Stem Cell Transplantation Infant

Key Points

To evaluate the effectiveness of ECMO in managing severe RSV-induced ARDS in an infant post-HSCT.
Presented a case study of a 10-month-old infant
Utilized venoarterial ECMO support
Examined management strategies for immunocompromised children with respiratory distress
The infant was successfully supported on VA ECMO
Management strategies improved clinical outcomes
Demonstrated the complexity of treating RSV ARDS in post-HSCT infants

Abstract

Respiratory syncytial virus (RSV) infection significantly increases morbidity and mortality in immunocompromised patients, especially those undergoing hematopoietic stem cell transplantation (HSCT).Recent advancements in ECMO and HSCT management have improved survival in this population.We present a complex case of a 10-month-old post-HSCT infant who required venoarterial (VA) ECMO support for severe RSV-associated ARDS, highlighting the challenges and strategies in managing immunocompromised children on ECMO.

Bookmark

View Full Paper

Cite This Study

Mehta et al. (Mon,) studied this question.

synapsesocial.com/papers/69e07d8f2f7e8953b7cbe7fa https://doi.org/https://doi.org/10.5005/jaypee-journals-11011-0095

Bookmark

View Full Paper